Reshape has developed a robotic imaging system replete with software and AI models to help scientists track visual changes from Petri dishes and similar plate formats.
With the news that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly accelerating by leaps and bounds. However, harvesting st
There’s a new generative AI startup based in Paris. But what makes Bioptimus interesting is that it plans to apply everything we’ve collectively learned about AI models over the past few years wit
Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. The company exited stealth a little ov
This pitch deck makes for some really interesting reading and storytelling, so let's dive in and see if we can spot what happened and how.
Welcome back to Found, where we get the stories behind the startups. This week we talk with Professor Esther Rodriguez-Villegas from Acurable.
Reed Jobs’ new venture firm can change the lives of the estimated 18.1 million diagnosed cancer patients worldwide. Yosemite, Jobs’ fund for cancer-fighting biotech, launched in August with $200 m
There’s a gold rush on in biotech as AI and other tools are used to find new drugs and treatments. With $5.5 million in new funding, Scala Biodesign is focusing these methods on a related proble
Startups are so full of shit right now. The pipes are jammed and there are so many companies that are full to bursting with the desire to un-pack them. We’ve just been through determining the sh
Welcome back to Found, where we get the stories behind the startups. This week, Becca and Dom are joined by Stacy Blain, the co-founder and chief science officer at Concarlo Therapeutics. Blain talked
How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look.
While generative AI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. There is also the process of using biology: the idea of using stem cells to create bi
Welcome back to Found, where we get the stories behind the startups. This week Darrell and Becca are joined by Trevor Martin the co-founder and CEO of Mammoth Biosciences, a startup that uses CRISPR t
A brown macroalgae native to the Atlantic’s Sargasso Sea is increasingly a menace to coastal ecosystems and communities across the Gulf of Mexico, ever since mats of the normally beneficial seaw
When you think of life sciences and biotech hubs in the U.S., where do you travel to in your mind? Boston? The Bay Area? Texas? Portal Innovations, a biotech VC firm based in Chicago, is trying to bro
To ensure survival, it’s essential to explore alternative funding methods rather than relying solely on classic fundraising.
Adding predictive LTV to your startup’s marketing strategy may literally help you stop throwing money away.
While not totally immune to 2022's market correction, biotech fundraising proved to be more resilient than other sectors.
"Growth at all costs" is a fairy tale made possible by cheap money that helped VCs set expectations for founders — and each other.
On the heels of the Biden administration’s decision to impose sweeping chip sanctions on China, there are signs that China might also lose access to other types of critical U.S. technologies, in
Load More